Table 4.
district/nation | year | Test method | Aminoglycosides | Fluoroquinolones | Carbapenems | Sulfonamides | source | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMK | TOB | FOX | MXF | CIP | CLR | DOX | IMP | MEM | LNZ | SXT/SOX3 | ||||
Shanghai | 2017 | 1 | 0 (0%) | 0 (0%) | 15 (88%) | 10 (59%) | 8 (47%) | 17 (100%) | 15 (88%) | 2 (12%) | - | 3 (18%) | 14 (82%) | This study |
Guangzhou | 2017 | 1 | 7 (14%) | 51 (100%) | - | 2 (4%) | 21 (41%) | 39 (76%) | - | 29 (57%) | 13 (25%) | 43 (84%) | - | [34] |
Mumbai | 2016 | 2 | 0 (0%) | 0 (0%) | 22 (100%) | - | 5 (23%) | 0 (0%) | - | 4 (18%) | - | 0 (0%) | 21 (95%) | [35] |
India | 2016 | 1 | 0 (0%) | - | - | - | 5 (24%) | 3 (14%) | - | - | - | - | - | [36] |
Iran | 2016 | 1 | 1 (2%) | 0 (0%) | 8 (14%) | 25 (29%) | 12(14%) | - | 36 (42%) | 8 (9%) | 42 (49%) | 6 (7%) | 0 (0%) | [37] |
Singapore | 2015 | 1 | 3 (3%) | 73 (92%) | 7 (8%) | 0 (0%) | 3 (3%) | 44 (47%) | - | 3 (3%) | 6 (7%) | 1 (3%) | [27] | |
Taiwan | 2003 | 1 | 0 (0%) | 32 (46%) | 1 (1%) | 17 (25%) | 23(33%) | 14 (20%) | 47 (68%) | 5 (7%) | 28 (41%) | 17 (25%) | 35 (51%) | [33] |
(1) 1 means broth microdilution method and 2 means disc diffusion method.
(2) “-“ means the results are not available.
(3) SXT=trimethoprim-sulfamethoxazole. SXT and SOX have the same mainly effective ingredient sulfamethoxazole, so we compare the results together.